Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2014 | An all-molecular diagnostic approach for myeloma

Gareth Morgan • 6 Dec 2014
ASH 2014
Multiple Myeloma

At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Gareth Morgan (University of Arkansas for Medical Sciences, Little Rock, AR; The Institute of Cancer Research, London, UK) discusses high-throughput genetic profiling with an ‘all-molecular’ diagnostic test for recurrent structural aberrations in multiple myeloma. It is hoped this approach will enable molecular risk-stratified clinical trial design and risk-adapted precision medicine for high-risk patients.

More from Gareth Morgan

2:19
How cutting-edge research is changing outcomes in myeloma and the need for novel endpoints in trials
Gareth Morgan • 10 Dec 2023
1:48
Investigating the non-coding myeloma genome
Gareth Morgan • 10 Dec 2023
1:29
Structural variation is a key driver of relapse and aggressive clinical behavior in multiple myeloma
Gareth Morgan • 10 Dec 2023
1:46
Personalizing treatment in multiple myeloma: approaching patients with t(4;14) and t(11;14)
Gareth Morgan • 29 Sep 2023

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals